Product Information

CEFPROZIL 125 MG/5 ML SUSP is a generic product labeled by NorthStar Rx LLC, priced at $0.1061 per ML under NDC 16714039603. Its NADAC has been published 626 times since Aug 27, 2014.

FDA first approved this application on Jan 30, 2007. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

CEFPROZIL 125 MG/5 ML SUSP

Cefprozil
$0.1061per ML

Strength

125 mg/5mL

Manufacturer

NorthStar Rx LLC

NDC

16714039603

Classification

Generic

Dosage Form

POWDER, FOR SUSPENSION

Route

ORAL

Effective Date

8/19/2026

Active Ingredients

CEFPROZIL

Approval Type

Generic (ANDA)

FDA Application

ANDA065381

FDA Approved

1/30/2007

TE Code

AB

On Market Since

1/30/2007

Price Statistics

The NADAC for CEFPROZIL 125 MG/5 ML SUSP has been published 626 times since Aug 27, 2014, and over the history we have for it it has declined 64.7%. The table below summarizes its recorded NADAC range and movement.

Current price$0.1061 per ML
All-time high$0.3071 (Feb 11, 2015)
All-time low$0.0917 (Jan 18, 2023)
52-week high$0.1421
52-week low$0.0986
Median price$0.1708
Average price$0.1909
Largest weekly change+73.0% (May 18, 2022)
Weeks tracked626
Tracking sinceAug 27, 2014

Price History

1W

-8.7%

1M

-8.7%

3M

-7.9%

6M

+7.4%

1Y

-25.3%

3Y

-27.7%

5Y

-43.2%

All

-64.7%

Generic Alternatives

The matcher finds 3 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 11% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Related Drugs

Same classification

No related drugs found.

Frequently asked questions

What is the NADAC price of CEFPROZIL 125 MG/5 ML SUSP?

The current National Average Drug Acquisition Cost (NADAC) for CEFPROZIL 125 MG/5 ML SUSP, manufactured by NorthStar Rx LLC, is $0.1061 per ML (NDC 16714039603), effective Aug 19, 2026.

How has the price of CEFPROZIL 125 MG/5 ML SUSP changed over time?

Over the history we have for it, the NADAC for CEFPROZIL 125 MG/5 ML SUSP has declined 64.7%. It has been tracked across 626 weekly CMS publications since Aug 27, 2014.

What are the highest and lowest recorded NADAC prices for CEFPROZIL 125 MG/5 ML SUSP?

Since Aug 27, 2014, the NADAC for CEFPROZIL 125 MG/5 ML SUSP has ranged from a low of $0.0917 (Jan 18, 2023) to a high of $0.3071 (Feb 11, 2015), with a median of $0.1708 per ML.

Are there cheaper alternatives to CEFPROZIL 125 MG/5 ML SUSP?

Yes. 3 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, CEFPROZIL 125 MG/5 ML SUSP, is $0.0943 per ML — about 11% below CEFPROZIL 125 MG/5 ML SUSP.

Who manufactures CEFPROZIL 125 MG/5 ML SUSP?

CEFPROZIL 125 MG/5 ML SUSP (NDC 16714039603) is labeled by NorthStar Rx LLC, and CMS classifies it as a generic product.